LifeSpan Biosciences

Name

LifeSpan Biosciences

Legal name

LifeSpan BioSciences, Inc.

Website

https://lsbio.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

LifeSpan Biosciences (LSBio) is a private life science reagent company that supplies validated antibodies, ELISA and assay kits, proteins, and IHC reagents to academic, pharmaceutical, and biotechnology researchers worldwide, operating under Vector Laboratories, Inc.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Research antibodies
• ELISA kits
• Immunohistochemistry reagents
• Recombinant proteins
• Life science reagents

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Antibody Product Sales: Sale of monoclonal and polyclonal antibodies covering all major research species, applications, and available in multiple conjugated forms. Collection of 421,628 antibodies. Revenue generated through per-unit product sales.
2. ELISA and Assay Kit Sales: Sale of Traditional Sandwich, Competitive EIA, Direct ELISA kits, Cell-Based ELISA kits, DNA-Binding ELISA kits, Phospho-Specific ELISA kits, Chemiluminescent CLIA kits, and ELISA Development kits. Collection includes over 38,000 Traditional ELISA kits and 1,679 Cell-Based ELISA kits.
3. Protein Product Sales: Sale of recombinant proteins, native proteins, over-expression lysates, bio-active proteins, animal-free proteins, synthetic peptides, and cell and tissue lysates.
4. Assay Kit Sales: Sale of assay kits for monitoring biological processes including cell viability, cytotoxicity, apoptosis, metabolism, signaling pathways. 170 Assay kits available.
5. IHC Reagent Sales: Sale of immunohistochemistry reagents including blocking agents, ABC detection kits, special/counter stains, antigen retrieval solutions, detection polymers, substrates, and mounting media.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

LifeSpan Biosciences (LSBio) develops, validates, and distributes a catalog of life science research reagents, including over 421,000 monoclonal and polyclonal antibodies, more than 38,000 ELISA kits across multiple formats, recombinant and native proteins, and immunohistochemistry reagents. The company specializes in IHC-validated antibodies with proprietary multi-tissue validation on human FFPE samples, supplying researchers and pharmaceutical/biotech customers with documented, application-specific reagents.

Product overview

LifeSpan BioSciences (LSBio) is a life science reagents company operating as part of the Vector Laboratories family, offering a comprehensive portfolio of research products centered around validated antibodies, immunoassays, and proteins. The core offering includes 421,628 monoclonal and polyclonal antibodies with specialized IHC validation (IHC-plus™ and PathPlus™ sub-brands), over 38,000 Traditional ELISA kits plus Cell-Based, DNA-Binding, Phospho-Specific, and Chemiluminescent ELISA variants, 170 specialized Assay Kits for metabolic and cellular analysis, recombinant and native proteins with multiple purity grades, and complete IHC reagents including detection systems and substrates. The product ecosystem spans general research antibodies, disease-specific research areas (cancer IHC, neurodegenerative disease, virology including coronavirus), and specialized assay platforms for transcription factor analysis and phosphorylation studies. All products are backed by the LSBio Guarantee and include technical support.

Differentiator

Problem solved

Functional benefit

Brands

• IHC-plus™ Antibodies: A subset of antibodies tested in IHC against a broad panel of normal human formalin-fixed paraffin-embedded (FFPE) tissue types demonstrating excellent sensitivity and specificity
• PathPlus™ Antibodies
• LSBio Advantage

Products and services

• Antibodies Collection of 421,628 monoclonal and polyclonal antibodies covering all major research species, applications, and multiple conjugated forms. Includes IHC-plus and PathPlus validated tiers for use in FFPE human tissue immunohistochemistry. Used by life science researchers in academic, industrial, and pharmaceutical settings.
• ELISA and Assay Kits

Quantifiable outcome

• Each antibody tested at minimum 4 dilutions on 22+ human tissue types
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Vector LaboratoriescoreStrategic or Co-development PartnerVector Laboratories operates as the corporate entity for LSBio, located at 6737 Mowry Avenue, Newark, CA 94560. The company recently merged with Absolute Biotech, significantly expanding capabilities as a critical component manufacturer for life science customers.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Abcam: Abcam is the leading independent antibody and research-reagent supplier with a comparable catalog of primary antibodies, ELISA kits, and proteomics tools. Acquired by Danaher in 2024, it is the closest direct competitor to LSBio in IHC-validated antibodies and immunoassay kits for academic and pharma researchers.
• Cell Signaling Technology: CST is a privately held specialist in antibody and ELISA products focused on signaling pathways, with rigorous validation standards similar to LSBio's IHC-plus/PathPlus approach. It is a primary competitor in phospho-specific antibodies and cell-based assays.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology sells research antibodies, ELISA kits, and lab reagents with a broad catalog directly comparable to LSBio's. It competes head-to-head in primary/secondary antibodies across cancer, neuroscience, and infectious disease research areas.
• Atlas Antibodies: Atlas Antibodies specializes in IHC-validated, tissue-microarray-tested antibodies (Triple A Polyclonals, PrecisA Monoclonals), with a validation approach and IHC focus nearly identical to LSBio's PathPlus™. It is a focused direct peer in the IHC-validated antibody niche.

Broad incumbents

• Bio-Techne (Novus Biologicals): Bio-Techne operates a broad life-science research tools portfolio that includes Novus Biologicals antibodies and Tocris assay reagents, directly overlapping with LSBio's antibody, protein, and assay kit catalog. As a public, scaled incumbent it competes on validation depth and distribution reach.
• Thermo Fisher Scientific (Life Science Research): Thermo Fisher's laboratory products division offers Invitrogen and Thermo Scientific antibodies, ELISA kits, and IHC reagents. It is a broad incumbent whose scale, catalog breadth, and preferred-vendor agreements with pharma pose significant competitive pressure on LSBio.

Emerging players

• Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies and assay reagents for life-science research with overlapping applications in IHC, ELISA, and Western blot. It is a privately held, mid-sized peer competing for similar academic and biotech customers.
• GenScript: GenScript provides custom antibody services, catalog antibodies, and ELISA kits, with growing overlap in recombinant antibody engineering and validated reagent lines. It is a global peer increasingly competing in LSBio's IHC and immunoassay niches.
• Proteintech Group: Proteintech manufactures antibodies and immunoassay kits with rigorous knockout/knockdown validation claims, directly mirroring LSBio's validation-centric value proposition. It is a fast-growing private peer competing for the same academic/biotech researcher wallet share.
• Bethyl Laboratories: Bethyl Laboratories produces rabbit monoclonal and polyclonal antibodies with strong validation in IHC and Western blot, comparable to LSBio's catalog. Now part of Epredia, it competes in the same research-reagent category for cancer and cell-biology applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lsbio
• Facebookfacebook.com/pages/category/Biotechnology-Company/LSBio-152003528149127
• LinkedInlinkedin.com/company/lsbio

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSpan Biosciences